Product Code: ETC6506103 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Geographic Atrophy Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Geographic Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Geographic Atrophy Market - Industry Life Cycle |
3.4 Brazil Geographic Atrophy Market - Porter's Five Forces |
3.5 Brazil Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 Brazil Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Brazil Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
4 Brazil Geographic Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Brazil |
4.2.2 Growing awareness and diagnosis of geographic atrophy in the country |
4.2.3 Technological advancements in diagnostic tools and treatment options for geographic atrophy |
4.3 Market Restraints |
4.3.1 High cost of treatment for geographic atrophy |
4.3.2 Limited access to specialized healthcare services in certain regions of Brazil |
4.3.3 Regulatory challenges and approval processes for new treatments in the market |
5 Brazil Geographic Atrophy Market Trends |
6 Brazil Geographic Atrophy Market, By Types |
6.1 Brazil Geographic Atrophy Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Brazil Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F |
6.1.3 Brazil Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.1.4 Brazil Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2 Brazil Geographic Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Brazil Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F |
6.2.3 Brazil Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F |
6.2.4 Brazil Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F |
6.3 Brazil Geographic Atrophy Market, By Therapeutic Agents Clinical Phase |
6.3.1 Overview and Analysis |
6.3.2 Brazil Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F |
6.3.3 Brazil Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 Brazil Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F |
7 Brazil Geographic Atrophy Market Import-Export Trade Statistics |
7.1 Brazil Geographic Atrophy Market Export to Major Countries |
7.2 Brazil Geographic Atrophy Market Imports from Major Countries |
8 Brazil Geographic Atrophy Market Key Performance Indicators |
8.1 Number of new cases diagnosed with geographic atrophy annually |
8.2 Adoption rate of advanced diagnostic tools for geographic atrophy |
8.3 Patient satisfaction rates with available treatment options |
8.4 Research and development investments in innovative therapies for geographic atrophy |
8.5 Number of healthcare professionals trained in diagnosing and managing geographic atrophy |
9 Brazil Geographic Atrophy Market - Opportunity Assessment |
9.1 Brazil Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 Brazil Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Brazil Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
10 Brazil Geographic Atrophy Market - Competitive Landscape |
10.1 Brazil Geographic Atrophy Market Revenue Share, By Companies, 2024 |
10.2 Brazil Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |